Home › Funds › Parkman Healthcare Partners LLC › WAT
Parkman Healthcare Partners LLC position in WAT
WATERS CORP · Industrials
Parkman Healthcare Partners LLC reported holding 27,878 shares of WAT (WATERS CORP) in its Q3 2026 13F filing — a position valued at US$12.2M, representing 1.11% of its reported portfolio and ranking #36 among its reported holdings. Parkman Healthcare Partners LLC has disclosed WAT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Parkman Healthcare Partners LLC's WAT position evolved
Parkman Healthcare Partners LLC first disclosed a stake in WAT in Q4 2025 at 41,899 shares (US$15.9M). Across 4 filings, Parkman Healthcare Partners LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 27,878 shares valued at US$12.2M — a reduction of -2,328 shares quarter over quarter.. Notable position changes include a 37% trim in Q1 2026 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 41.90K | $15.91M | New |
| Q1 2026 | 26.45K | $7.88M | Reduce |
| Q2 2026 | 30.21K | $11.33M | Add |
| Q3 2026 | 27.88K | $12.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About WAT and 13F data
WAT (WATERS CORP) is a Industrials company. 45 other funds we track also report a position in WAT — the largest reported positions include MFS Investment Management (US$2.82B), T. Rowe Price Investment Management, Inc. (US$1.43B), Fundsmith LLP (US$995.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WAT
- MFS Investment Management 4.40M sh · $2.82B · Q3 2026
- T. Rowe Price Investment Management, Inc. 3.82M sh · $1.43B · Q2 2026
- Fundsmith LLP 2.27M sh · $995.87M · Q3 2026
- Viking Global Investors 1.66M sh · $623.37M · Q2 2026
- VIKING GLOBAL INVESTORS LP 1.66M sh · $623.37M · Q2 2026
- Mawer Investment Management Ltd. 982.61K sh · $431.75M · Q3 2026
- FUNDSMITH INVESTMENT SERVICES LTD. 810.43K sh · $356.10M · Q3 2026
- D. E. Shaw & Co., Inc. 948.64K sh · $355.78M · Q2 2026
- Veritas Asset Management LLP 765.14K sh · $336.19M · Q3 2026
- MILLENNIUM MANAGEMENT LLC 894.66K sh · $335.53M · Q2 2026
- Holocene Advisors, LP 847.77K sh · $317.95M · Q2 2026
- Allspring Global Investments Holdings, LLC 682.45K sh · $290.40M · Q3 2026
More on Parkman Healthcare Partners LLC
FAQ
How long has Parkman Healthcare Partners LLC held WAT?
Parkman Healthcare Partners LLC has disclosed WAT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Parkman Healthcare Partners LLC's current position in WAT?
As of Q3 2026, Parkman Healthcare Partners LLC holds 27.88K shares of WAT (WATERS CORP), valued at $12.25M, representing 1.11% of its reported portfolio and ranking #36.
Has Parkman Healthcare Partners LLC been buying or selling WAT?
In the latest 13F filing (Q3 2026), Parkman Healthcare Partners LLC reduced its position in WAT.
Which other funds hold WAT?
Other major institutional holders of WAT include MFS Investment Management, T. Rowe Price Investment Management, Inc., Fundsmith LLP, among 45 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.